Hervolution Therapeutics

📍 Copenhagen N, Denmark👥 20 employees💰 Last funded Jun 2023
Immune therapy platform targeting Dark Genome antigens that contribute to aging, cancer, diabetes, and neurodegenerative diseases
7
Total investors
0
Early stage
7
Mid stage
0
Late stage
Founded
Investor geography2 countries
Denmark
6
Canada
1
Investor activity2021–2023 · investors recorded per year
202122022420231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Hervolution Therapeutics?
Hervolution Therapeutics has 7 investors on record on gritt.io, 7 mid-stage.
When did Hervolution Therapeutics last raise funding?
The most recent investment in Hervolution Therapeutics recorded on gritt.io was in June 2023.
What industry is Hervolution Therapeutics in?
Hervolution Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Hervolution Therapeutics based?
Hervolution Therapeutics is headquartered in Copenhagen N, Denmark.